-
Tytuł:
-
A Preparedness Model for Mother-Baby Linked Longitudinal Surveillance for Emerging Threats.
-
Autorzy:
-
Woodworth KR; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA. .
Reynolds MR; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.
Burkel V; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.; Eagle Medical Services and Eagle Global Scientific, LLC, Atlanta, USA.
Gates C; Arizona Department of Health Services, Phoenix, USA.
Eckert V; California Department of Public Health, Sacramento, USA.
McDermott C; Florida Department of Health, Tallahassee, USA.
Barton J; Georgia Department of Public Health, Atlanta, USA.
Wilburn A; Kentucky Department for Public Health, Frankfort, USA.
Halai UA; Los Angeles County Department of Public Health, Los Angeles, USA.
Brown CM; Massachusetts Department of Public Health, Boston, USA.
Bocour A; New York City Department of Health & Mental Hygiene, Long Island City, USA.
Longcore N; New York State Department of Health, Albany, USA.
Orkis L; Pennsylvania Department of Health, Pittsburgh, USA.
Lopez CD; Puerto Rico Department of Health, San Juan, USA.
Sizemore L; Tennessee Department of Health, Nashville, USA.
Ellis EM; U.S. Virgin Islands Department of Health, Christiansted, USA.
Schillie S; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, USA.
Gupta N; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, USA.
Bowen VB; Division of STD Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, CDC, Atlanta, USA.
Torrone E; Division of STD Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, CDC, Atlanta, USA.
Ellington SR; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, USA.
Delaney A; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.; Eagle Medical Services and Eagle Global Scientific, LLC, Atlanta, USA.
Olson SM; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.; G2S Corporation, San Antonio, USA.
Roth NM; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.; Eagle Medical Services and Eagle Global Scientific, LLC, Atlanta, USA.
Whitehill F; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.; Oak Ridge Institute for Science and Education, Oak Ridge, USA.
Zambrano LD; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.
Meaney-Delman D; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.
Fehrenbach SN; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.
Honein MA; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.
Tong VT; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.
Gilboa SM; Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention (CDC), 4770 Buford Highway NE, Atlanta, GA, 30341, USA.
-
Źródło:
-
Maternal and child health journal [Matern Child Health J] 2021 Feb; Vol. 25 (2), pp. 198-206. Date of Electronic Publication: 2021 Jan 04.
-
Typ publikacji:
-
Journal Article
-
Język:
-
English
-
Imprint Name(s):
-
Publication: 1999- : New York, NY : Kluwer Academic/Plenum Publishers
Original Publication: New York : Plenum Press, c1997-
-
MeSH Terms:
-
Mother-Child Relations*
Civil Defense/*methods
Population Surveillance/*methods
Adult ; COVID-19/complications ; COVID-19/diagnosis ; Civil Defense/instrumentation ; Female ; Hepatitis C/complications ; Hepatitis C/diagnosis ; Humans ; Infant, Newborn ; Mass Screening/methods ; Pregnancy ; Syphilis/complications ; Syphilis/diagnosis
-
References:
-
Alaali, Z. S., Longcore, N. D., Santos, P., Glaze, V. H., & Ahmad, N. (2020). Methods of tracking newborns: New York State Zika Pregnancy and Infant Registry, 2015–2017. American Journal of Public Health, 110(2), 216–221. https://doi.org/10.2105/AJPH.2019.305406 . (PMID: 10.2105/AJPH.2019.30540631855479)
Benova, L., Mohamoud, Y. A., Calvert, C., & Abu-Raddad, L. J. (2014). Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clinical Infectious Diseases, 59(6), 765–773. https://doi.org/10.1093/cid/ciu447 . (PMID: 10.1093/cid/ciu447249282904144266)
Bowen, V., Su, J., Torrone, E., Kidd, S., & Weinstock, H. (2015). Increase in incidence of congenital syphilis—United States, 2012–2014. Morbidity and Mortality Weekly Report, 64(44), 1241–1245. https://doi.org/10.15585/mmwr.mm6444a3 . (PMID: 10.15585/mmwr.mm6444a326562206)
Centers for Disease Control and Prevention. (2019). Surveillance for viral hepatitis—United States, 2017. Retrieved February 7, 2020 from https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm .
Chappell, C. A., Hillier, S. L., Crowe, D., Meyn, L. A., Bogen, D. L., & Krans, E. E. (2018). Hepatitis C virus screening among children exposed during pregnancy. Pediatrics, 141(6), e20173273. https://doi.org/10.1542/peds.2017-3273 . (PMID: 10.1542/peds.2017-3273297205355984711)
Council of State and Territorial Epidemiologists. (2015). Congenital syphilis (Treponema pallidum) 2015 case definition. Retrieved May 19, 2020 from https://wwwn.cdc.gov/nndss/conditions/congenital-syphilis/case-definition/2015/ .
Council of State and Territorial Epidemiologists. (2018). Hepatitis C, perinatal infection. Retrieved May 19, 2020 from https://wwwn.cdc.gov/nndss/conditions/hepatitis-c-perinatal-infection/case-definition/2018/ .
Ellington, S., Strid, P., Tong, V. T., Woodworth, K., Galang, R. R., Zambrano, L. D., et al. (2020). Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020. Morbidity and Mortality Weekly Report, 69(25), 769–775. https://doi.org/10.15585/mmwr.mm6925a1 . (PMID: 10.15585/mmwr.mm6925a1325847957316319)
Frey, M. T., Meaney-Delman, D., Bowen, V., Yazdy, M. M., Watkins, S. M., Thorpe, P. G., et al. (2019). Surveillance for emerging threats to pregnant women and infants. Journal of Women’s Health (Larchmt), 28(8), 1031–1036. https://doi.org/10.1089/jwh.2019.7943 . (PMID: 10.1089/jwh.2019.7943)
Gomez, G. B., Kamb, M. L., Newman, L. M., Mark, J., Broutet, N., & Hawkes, S. J. (2013). Untreated maternal syphilis and adverse outcomes of pregnancy: A systematic review and meta-analysis. Bulletin of the World Health Organization, 91(3), 217–226. https://doi.org/10.2471/BLT.12.107623 . (PMID: 10.2471/BLT.12.107623234760943590617)
Honein, M. A., Dawson, A. L., Petersen, E. E., Jones, A. M., Lee, E. H., Yazdy, M. M., et al. (2017). Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. Journal of the American Medical Association, 317(1), 59–68. https://doi.org/10.1001/jama.2016.19006 . (PMID: 10.1001/jama.2016.1900627960197)
Kimball, A., Torrone, E., Miele, K., Bachmann, L., Thorpe, P., Weinstock, H., et al. (2020). Missed opportunities for prevention of congenital syphilis—United States, 2018. Morbidity and Mortality Weekly Report, 69(22), 661–665. https://doi.org/10.15585/mmwr.mm6922a1 . (PMID: 10.15585/mmwr.mm6922a1324970297272112)
Kirtsman, M., Diambomba, Y., Poutanen, S. M., Malinowski, A. K., Vlachodimitropoulou, E. W., Parks, T., et al. (2020). Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection. Canadian Medical Association Journal, 192(24), E647–E650. https://doi.org/10.1503/cmaj.200821 . (PMID: 10.1503/cmaj.20082132409520)
Patrick, S. W., Bauer, A. M., Warren, M. D., Jones, T. F., & Wester, C. (2017). Hepatitis C virus infection among women giving birth—Tennessee and United States, 2009–2014. Morbidity and Mortality Weekly Report, 66(18), 470–473. https://doi.org/10.15585/mmwr.mm6618a3 . (PMID: 10.15585/mmwr.mm6618a3284938605657980)
Rasmussen, S. A., & Hayes, E. B. (2005). Public health approach to emerging infections among pregnant women. American Journal of Public Health, 95(11), 1942–1944. https://doi.org/10.2105/AJPH.2004.054957 . (PMID: 10.2105/AJPH.2004.054957161955181449464)
Schillie, S., Wester, C., Osborne, M., Wesolowski, L., & Ryerson, A. B. (2020). CDC recommendations for hepatitis C screening among adults—United States, 2020. MMWR Recommendations and Reports, 69(2), 1–17. https://doi.org/10.15585/mmwr.rr6902a1 . (PMID: 10.15585/mmwr.rr6902a1326148117147910)
Wingate, H., Sizemore, L., Black, J., & Wester, C. (2019). Retrospective surveillance of perinatal hepatitis C virus exposure—Tennessee, 2013–2017 [Conference presentation abstract]. International Society for Disease Conference, San Diego, CA.
Workowski, K. A., Bolan, G. A., & Centers for Disease Control and Prevention. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports, 64(RR-03), 1–137. (PMID: 26042815)
-
Grant Information:
-
ELC CK19-1904 United States CC CDC HHS; ELC CK19-1904 United States CC CDC HHS
-
Contributed Indexing:
-
Keywords: COVID-19; Congenital infection; Congenital syphilis; Perinatal hepatitis C; Pregnancy; SARS-CoV-2; Surveillance
-
Entry Date(s):
-
Date Created: 20210104 Date Completed: 20210215 Latest Revision: 20210215
-
Update Code:
-
20240105
-
PubMed Central ID:
-
PMC7780211
-
DOI:
-
10.1007/s10995-020-03106-y
-
PMID:
-
33394275
-
Introduction: Public health responses often lack the infrastructure to capture the impact of public health emergencies on pregnant women and infants, with limited mechanisms for linking pregnant women with their infants nationally to monitor long-term effects. In 2019, the Centers for Disease Control and Prevention (CDC), in close collaboration with state, local, and territorial health departments, began a 5-year initiative to establish population-based mother-baby linked longitudinal surveillance, the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET).
Objectives: The objective of this report is to describe an expanded surveillance approach that leverages and modernizes existing surveillance systems to address the impact of emerging health threats during pregnancy on pregnant women and their infants.
Methods: Mother-baby pairs are identified through prospective identification during pregnancy and/or identification of an infant with retrospective linking to maternal information. All data are obtained from existing data sources (e.g., electronic medical records, vital statistics, laboratory reports, and health department investigations and case reporting).
Results: Variables were selected for inclusion to address key surveillance questions proposed by CDC and health department subject matter experts. General variables include maternal demographics and health history, pregnancy and infant outcomes, maternal and infant laboratory results, and child health outcomes up to the second birthday. Exposure-specific modular variables are included for hepatitis C, syphilis, and Coronavirus Disease 2019 (COVID-19). The system is structured into four relational datasets (maternal, pregnancy outcomes and birth, infant/child follow-up, and laboratory testing).
Discussion: SET-NET provides a population-based mother-baby linked longitudinal surveillance approach and has already demonstrated rapid adaptation to COVID-19. This innovative approach leverages existing data sources and rapidly collects data and informs clinical guidance and practice. These data can help to reduce exposure risk and adverse outcomes among pregnant women and their infants, direct public health action, and strengthen public health systems.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
